Drugs / Lidorestat
Follow
re-read 3 minutes ago
Lidorestat
also known as
EML 676 · IDD 676 · IDD-000676 · IDD-000676-01 · Lidorestat anhydrous · Lindolrestat · Lindorestat
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00043797 | — | diabetic polyneuropathy | The Institute for Diabetes Discovery, LLC | Unknown | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lidorestat | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00043797 ↗ |
| Known as | EML 676 | ChEMBL registry synonym — accepted as the source's own label CHEMBL363387 ↗ |
| Known as | IDD 676 | “Lidorestat (IDD 676)” NCT00043797 ↗ |
| Known as | IDD-000676 | ChEMBL registry synonym — accepted as the source's own label CHEMBL363387 ↗ |
| Known as | IDD-000676-01 | ChEMBL registry synonym — accepted as the source's own label CHEMBL363387 ↗ |
| Known as | Lidorestat anhydrous | ChEMBL registry synonym — accepted as the source's own label CHEMBL363387 ↗ |
| Known as | Lindolrestat | ChEMBL registry synonym — accepted as the source's own label CHEMBL363387 ↗ |
| Known as | Lindorestat | ChEMBL registry synonym — accepted as the source's own label CHEMBL363387 ↗ |
| Modality | Small molecule | — CHEMBL363387 ↗ |